First Trust Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.55M | Buy |
48,840
+16,570
| +51% | +$1.88M | ﹤0.01% | 1312 |
|
2025
Q1 | $3.39M | Sell |
32,270
-1,056
| -3% | -$111K | ﹤0.01% | 1518 |
|
2024
Q4 | $3.57M | Sell |
33,326
-2,011
| -6% | -$215K | ﹤0.01% | 1549 |
|
2024
Q3 | $3.54M | Buy |
35,337
+3,502
| +11% | +$351K | ﹤0.01% | 1497 |
|
2024
Q2 | $2.68M | Buy |
31,835
+11,110
| +54% | +$936K | ﹤0.01% | 1570 |
|
2024
Q1 | $1.51M | Sell |
20,725
-492
| -2% | -$36K | ﹤0.01% | 1846 |
|
2023
Q4 | $1.52M | Buy |
21,217
+3,262
| +18% | +$233K | ﹤0.01% | 1836 |
|
2023
Q3 | $1.08M | Buy |
+17,955
| New | +$1.08M | ﹤0.01% | 1938 |
|
2023
Q2 | – | Sell |
-16,955
| Closed | -$1.25M | – | 2405 |
|
2023
Q1 | $1.25M | Buy |
16,955
+12,677
| +296% | +$933K | ﹤0.01% | 1899 |
|
2022
Q4 | $286K | Sell |
4,278
-6,721
| -61% | -$449K | ﹤0.01% | 2320 |
|
2022
Q3 | $947K | Sell |
10,999
-2,833
| -20% | -$244K | ﹤0.01% | 2018 |
|
2022
Q2 | $1.23M | Buy |
13,832
+5,883
| +74% | +$525K | ﹤0.01% | 1905 |
|
2022
Q1 | $894K | Buy |
7,949
+3,679
| +86% | +$414K | ﹤0.01% | 2080 |
|
2021
Q4 | $660K | Sell |
4,270
-8,279
| -66% | -$1.28M | ﹤0.01% | 2208 |
|
2021
Q3 | $1.75M | Sell |
12,549
-19,577
| -61% | -$2.73M | ﹤0.01% | 1819 |
|
2021
Q2 | $4.22M | Buy |
+32,126
| New | +$4.22M | ﹤0.01% | 1454 |
|
2021
Q1 | – | Sell |
-6,084
| Closed | -$605K | – | 2435 |
|
2020
Q4 | $605K | Sell |
6,084
-13,302
| -69% | -$1.32M | ﹤0.01% | 2070 |
|
2020
Q3 | $1.85M | Buy |
+19,386
| New | +$1.85M | ﹤0.01% | 1393 |
|
2019
Q1 | – | Sell |
-20,526
| Closed | -$2.79M | – | 2434 |
|
2018
Q4 | $2.79M | Sell |
20,526
-8,230
| -29% | -$1.12M | 0.01% | 1283 |
|
2018
Q3 | $7.89M | Buy |
28,756
+5,996
| +26% | +$1.65M | 0.01% | 912 |
|
2018
Q2 | $4.72M | Buy |
22,760
+10,217
| +81% | +$2.12M | 0.01% | 1126 |
|
2018
Q1 | $2.07M | Buy |
12,543
+30
| +0.2% | +$4.96K | ﹤0.01% | 1449 |
|
2017
Q4 | $1.71M | Buy |
12,513
+609
| +5% | +$83.4K | ﹤0.01% | 1605 |
|
2017
Q3 | $1.62M | Buy |
11,904
+7,584
| +176% | +$1.03M | ﹤0.01% | 1615 |
|
2017
Q2 | $524K | Buy |
+4,320
| New | +$524K | ﹤0.01% | 2045 |
|
2016
Q4 | – | Sell |
-21,352
| Closed | -$2.18M | – | 2469 |
|
2016
Q3 | $2.18M | Buy |
21,352
+4,487
| +27% | +$458K | 0.01% | 1287 |
|
2016
Q2 | $2.01M | Sell |
16,865
-3,245
| -16% | -$387K | 0.01% | 1311 |
|
2016
Q1 | $2.15M | Sell |
20,110
-248
| -1% | -$26.6K | 0.01% | 1265 |
|
2015
Q4 | $2.21M | Sell |
20,358
-12,733
| -38% | -$1.38M | 0.01% | 1337 |
|
2015
Q3 | $2.83M | Sell |
33,091
-2,999
| -8% | -$257K | 0.01% | 1202 |
|
2015
Q2 | $3.64M | Buy |
+36,090
| New | +$3.64M | 0.01% | 1175 |
|
2014
Q4 | – | Sell |
-24,859
| Closed | -$1.17M | – | 2280 |
|
2014
Q3 | $1.17M | Sell |
24,859
-11,720
| -32% | -$551K | ﹤0.01% | 1636 |
|
2014
Q2 | $2.28M | Sell |
36,579
-2,066
| -5% | -$129K | 0.01% | 1293 |
|
2014
Q1 | $2.6M | Buy |
+38,645
| New | +$2.6M | 0.01% | 1252 |
|